Yumi Yamashita-Kanemaru

5PUBLICATIONS
46CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 03, 2026
Tumor-derived antioxidants suppress immunity by depriving T cells of reactive oxygen species.

|Apr 09, 2026
Cortisol-resistant CAR-NK cells overcome steroid-induced immunosuppression in lung cancer.

Soura Chakraborty, Jhuma Pramanik, Gustavo Alviter-Raymundo

|Jan 16, 2026
Fine-tuning BACH2 dosage balances stemness and effector function to enhance antitumor T cell therapy.

Alberto G Conti, Alexander C Evans, Teresa von Linde

|Mar 05, 2025
Aspirin prevents metastasis by limiting platelet TXA2 suppression of T cell immunity.

Jie Yang, Yumi Yamashita-Kanemaru, Benjamin I Morris

|May 20, 2021
DNAM-1 regulates Foxp3 expression in regulatory T cells by interfering with TIGIT under inflammatory conditions.

Kazuki Sato, Yumi Yamashita-Kanemaru, Fumie Abe

Pageof 1

Frequent Collaborators

3 joint publications

Klaus Okkenhaug

3 joint publications

Charlotte J Imianowski

3 joint publications

Rahul Roychoudhuri

3 joint publications

Jie Yang